About Biowave
Biowave is a company based in Norwalk (United States) founded in 2000. Biowave has raised $2.08 million across 2 funding rounds. Biowave offers products and services including BioWavePRO, BioWavePENS, BioWaveHOME, BioWaveGO RX, and BioWraps. Biowave operates in a competitive market with competitors including Saluda Medical, Nalu Medical, Myoscience, Neuros Medical and Alpha-Stim, among others.
- Headquarter Norwalk, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biowave Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.08 M (USD)
in 2 rounds
-
Latest Funding Round
$1.33 M (USD), Seed
Dec 06, 2019
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biowave
Biowave offers a comprehensive portfolio of products and services, including BioWavePRO, BioWavePENS, BioWaveHOME, BioWaveGO RX, and BioWraps.
Wearable device for blocking severe pain in medical settings.
Non-surgical treatment providing up to 72 hours of pain relief.
Portable neurostimulation for personal chronic pain management.
Compact device offering up to 24 hours of fast pain relief.
Wearable compression for treating larger tissue areas with relief.
People of Biowave
Unlock access to complete
Unlock access to complete
Funding Insights of Biowave
Biowave has successfully raised a total of $2.08M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.33 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Biowave
Investment portfolio details for Biowave
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biowave
Detailed financials for Biowave
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biowave Comparisons
Peer comparison for Biowave
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biowave
Biowave operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Saluda Medical, Nalu Medical, Myoscience, Neuros Medical and Alpha-Stim, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment
|
|
| Locked | Locked | Locked |
Developer of a neurostimulation system for managing intractable chronic pain
|
|
| Locked | Locked | Locked |
Technology-driven dermatological products are developed and commercialized.
|
|
| Locked | Locked | Locked |
High-frequency neurostimulation therapies for chronic neuropathic pain are developed.
|
|
| Locked | Locked | Locked |
Non-drug electrotherapy devices for pain and anxiety are developed.
|
Detailed competitors of Biowave
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biowave
Complete news archive for Biowave
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biowave
Biowave was founded in 2000 and raised its 1st funding round 16 years after it was founded.
Biowave is headquartered in Norwalk, United States.
Biowave is a funded company, having raised a total of $2.08M across 2 funding rounds to date.
Biowave Corporation develops and markets neuromodulation pain therapy devices aiming to aid physicians, physical therapists, and athletic trainers manage their patients or athletes pain and reduce the use of drugs. The BiowavePRO and Homewave neuromodulation devices deliver a therapeutic electrical pulse into deep tissue in the body blocking the transmission of pain. The devices have received marketing clearance from the FDA (Sep 2015) and are indicated to treat musculoskeletal pain that is chronic, acute or post-operative in nature and located in the low back, cervical spine, shoulder, elbow, wrist, hand, hip, knee, ankle and foot.
Biowave's top competitors include Saluda Medical, Nalu Medical and Myoscience.
Biowave offers BioWavePRO, BioWavePENS, BioWaveHOME, BioWaveGO RX, and BioWraps.